Cipla, Ltd. · 66-66 · INDIA
For Cipla, Ltd., import alert is 66-66; country is INDIA; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Finasteride API; product code is 64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf; date published is 10/18/2010; address is Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA, verified against its source on 2026-09-30.
- Firm
- Cipla, Ltd. verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- INDIA verified
- Address
- Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA verified
- Date published
- 10/18/2010 verified
- Product code
- 64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf verified
- Product
- Finasteride API verified
What the source says
Cipla, Ltd. Date Published : 10/18/2010 Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code and Product
64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf Date Published: 10/18/2010 Desc: Finasteride API
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html